Search the Archive

Government / CBS Poll / Special Interests #996444

CBS Evening News for Tuesday, Jun 28, 2011
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

(Studio: Scott Pelley) The findings of a CBS News poll on who benefits from government policies and how Congress serves special interest groups outlined on screen.

(Washington: Nancy Cordes) Special fixes by Congress examined; details given about an amendment assuring the Medicines Co. keeps control of its patent for its blood-thinning drug Angiomax; poll figures cited. [Senator Mitch McCONNELL - says Americans never love Congress.] [Taxpayers for Common Sense Ryan ALEXANDER††- comments on tax credits.] [Medicines Co. CEO Dr. Clive MEANWELL††- reacts to the move by Congress.]

Pelley, Scott;
Cordes, Nancy

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.